| abstract |
The invention relates to an injectable drug with a long release, which is a dosage form used by the introduction, and which supports the effect of 7- [4- (4-benzo [b] thiophen-4-ylpiperazin-1-yl) butoxy] -1H- quinolin-2-it for a long period of time, where the specified drug releases a therapeutically effective amount of 7- [4- (4-benzo [b] thiophen-4-ylpiperazin-1-yl) butoxy] -1H-quinolin-2-one for at least one week. The invention relates to an injectable preparation containing 7- [4- (4-benzo [b] thiophen-4-ylpiperazin-1-yl) butoxy] -1H-quinolin-2-one or its salt as an active ingredient, which releases the active ingredient in such a mode that its concentration in the blood is maintained for at least one week. |